Terns Pharmaceuticals (TERN) Operating Expenses: 2020-2024
Historic Operating Expenses for Terns Pharmaceuticals (TERN) over the last 5 years, with Dec 2024 value amounting to $101.9 million.
- Terns Pharmaceuticals' Operating Expenses rose 13.11% to $16.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was $62.0 million, marking a year-over-year increase of 21.96%. This contributed to the annual value of $101.9 million for FY2024, which is 0.67% down from last year.
- Terns Pharmaceuticals' Operating Expenses amounted to $101.9 million in FY2024, which was down 0.67% from $102.6 million recorded in FY2023.
- Over the past 5 years, Terns Pharmaceuticals' Operating Expenses peaked at $102.6 million during FY2023, and registered a low of $37.0 million during FY2020.
- For the 3-year period, Terns Pharmaceuticals' Operating Expenses averaged around $88.8 million, with its median value being $101.9 million (2024).
- In the last 5 years, Terns Pharmaceuticals' Operating Expenses spiked by 65.34% in 2023 and then declined by 0.67% in 2024.
- Yearly analysis of 5 years shows Terns Pharmaceuticals' Operating Expenses stood at $37.0 million in 2020, then surged by 37.37% to $50.9 million in 2021, then increased by 21.96% to $62.0 million in 2022, then spiked by 65.34% to $102.6 million in 2023, then decreased by 0.67% to $101.9 million in 2024.